GeminIQ Website Logo

Viewing AVXL free

Subscribe for full history, 50+ metrics, screener, watchlist...

ANAVEX LIFE SCIENCES CORP.

AVXL

Companies in Biological Products, (No Diagnostic Substances)

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
132103101116121132139139144151155153
Income Taxes Receivable
111132244325
Prepaid Expense And Other Assets Current
000111111111
Assets
133104102117124136142145148154158159
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
3477510444446
Accrued Liabilities Current
3441085757767
Deferred Income Current
--111-111-11
Deferred Rent Credit
11---1---1--
Liabilities
6911171315121012131114
Preferred Stock Value
--0----0----
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
515477463459459456454447437435430417
Retained Earnings Accumulated Deficit
-388-382-373-359-348-336-324-312-302-293-283-272
Stockholders Equity
1279591100111120130135136142147145
Liabilities And Stockholders Equity
133104102117124136142145148154158159
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
1,2001,2001,2001,2001,2001,2001,2001,2001,2001,2001,2001,200
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Issued
278260256256255254254251246246244241
Shares Outstanding
938785858585858482828180

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20266.90%-31.26%-23.68%---------
2025-0.34%-5.86%7.59%1.85%32.88%37.93%-12.80%-7.61%-26.07%6.07%44.80%13.58%
2024-5.55%-8.94%-38.46%4.64%8.76%73.71%-11.67%-16.65%-23.11%-17.62%-23.79%-15.65%
2023---0.77%-10.36%-12.57%-1.12%-18.43%-35.24%40.72%-4.87%-10.85%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Leverage & Debt
Interest Coverage TTM
-10.22
-10.99
-10.08
-8.93
-8.22
-7.22
-6.82
-6.65
-7.13
-8.55
-11.09
-15.63
Per Share Metrics
Diluted EPS TTM
-0.45
-0.54
-0.56
-0.55
-0.55
-0.52
-0.49
-0.49
-0.53
-0.60
-0.64
-0.67
Free Cash Flow Per Share TTM
-0.38
-0.46
-0.43
-0.35
-0.42
-0.37
-0.35
-0.39
-0.36
-0.35
-0.32
-0.32
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Metrics
Net Income Growth (1Y)
-14.08%
7.85%
15.99%
16.13%
7.73%
-9.48%
-19.60%
-23.03%
-13.81%
-0.99%
13.75%
22.02%
EPS Growth (1Y)
-18.15%
5.55%
14.85%
12.57%
4.26%
-13.47%
-23.08%
-26.91%
-18.11%
-4.56%
228.88%
260.73%
Valuation Metrics
P/E TTM
-7.93
-16.37
-16.34
-15.48
-19.59
-11.03
-8.59
-10.34
-17.71
-11.00
-12.73
-12.72
P/B TTM
2.50
8.00
8.65
7.32
8.21
3.94
2.75
3.11
5.64
3.68
4.48
4.62
Market Cap
316.94M
759.08M
787.21M
729.93M
910.82M
474.10M
356.74M
419.74M
764.14M
522.61M
657.52M
671.07M
Enterprise Value
185.20M
656.50M
686.05M
614.16M
790.04M
341.91M
217.98M
280.36M
620.38M
371.58M
502.70M
517.60M
Calculated Values
Free Cash Flow TTM
-34.08M
-39.04M
-37.10M
-29.81M
-35.61M
-30.81M
-30.00M
-32.48M
-29.31M
-27.79M
-25.98M
-25.38M
Net Debt
-131.75M
-102.58M
-101.16M
-115.77M
-120.78M
-132.19M
-138.76M
-139.39M
-143.77M
-151.02M
-154.82M
-153.47M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2024-06-14Purchase
Owner: Donhauser, Peter D.O.
Title: -
Shares: 2,835
Price/Share: $3.64
Value: $10,319.40
Shares Owned: 5,000
Relationship: Director
Ownership: Direct
2024-05-15Purchase
Owner: Thomas, Steffen
Title: -
Shares: 5,000
Price/Share: $4.52
Value: $22,600.00
Shares Owned: 5,000
Relationship: Director
Ownership: Direct
2024-03-28Sale
Owner: Missling, Christopher U
Title: President and CEO
Shares: 73,380
Price/Share: $5.11
Value: $374,971.80
Shares Owned: 1,250,210
Relationship: Director,Officer
Ownership: Direct
2023-06-28Sale
Owner: Missling, Christopher U
Title: President and CEO
Shares: 268,000
Price/Share: $7.98
Value: $2,138,640.00
Shares Owned: 1,018,210
Relationship: Director,Officer
Ownership: Direct
2022-05-25Sale
Owner: Skarpelos, Athanasios
Title: -
Shares: 50,000
Price/Share: $9.06
Value: $453,000.00
Shares Owned: 1,306,458
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
43.32%
Inst. Shares: 38,566,477
Shares Outstanding: 89,029,458
2025-12-31
42.83%
Inst. Shares: 38,131,677
Shares Outstanding: 89,029,458
2025-09-30
37.36%
Inst. Shares: 31,862,842
Shares Outstanding: 85,289,447
2025-06-30
37.17%
Inst. Shares: 31,737,122
Shares Outstanding: 85,380,587
2025-03-31
35.81%
Inst. Shares: 30,468,615
Shares Outstanding: 85,073,769

ANAVEX LIFE SCIENCES CORP. (AVXL) — SEC Financial Statements & Analysis

ANAVEX LIFE SCIENCES CORP. (AVXL) is a biological products, (no diagnostic substances) company. ANAVEX LIFE SCIENCES CORP. trades on AVXL: Nasdaq as: AVXL. Based on its latest SEC filing (Form 10-Q, period ending 2025-12-31), ANAVEX LIFE SCIENCES CORP. reported a Price-to-Book (P/B) ratio of 2.5 (TTM), at a market cap of $316.94M. Figures below are sourced from SEC EDGAR, as-filed.

P/B TTM
2.5
Market Cap
$316.94M

Data as of 2025-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ANAVEX LIFE SCIENCES CORP. in?

ANAVEX LIFE SCIENCES CORP. (AVXL) operates in the Biological Products, (No Diagnostic Substances) industry.

What is AVXL's market cap?

ANAVEX LIFE SCIENCES CORP. (AVXL) has a market capitalization of $316.94M as of 2025-12-31.

What exchange does AVXL trade on?

ANAVEX LIFE SCIENCES CORP. (AVXL) trades on the AVXL: Nasdaq.

Research Faster.
Invest Smarter.

ANAVEX LIFE SCIENCES CORP. (AVXL) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.